Lumax 740 Series

 

 

 

 

 

 

 

Our passion for CRM has delivered the world's first ICD and CRT-D series approved for MRI*. 

The new Lumax 740 series is part of of BIOTRONIK's technologically advanced product portfolio of tachyarrhythmia therapy devices with the innovative ProMRI^® technology.

A portfolio of single- and dual-chamber ICDs as well as a CRT-D device, complemented by 16 leads enable physicians to provide patients access to MRI while having the freedom to select the optimal ICD system according to the patients' indication. 

Furthermore, Lumax 740 provides unique therapy options such as the world’s only single-chamber ICD with complete atrial diagnostics—the Lumax 740 VR-T DX. 

The new sensor analyses changes in impedance during the cycle of the heart and is being evaluated in clinical studies. This new feature aims to enhance therapy for heart failure patients in the future. 

Innovative solutions for heart failure patients are integrated in the Lumax 740 HF-T device that enables enhanced CRT effectiveness and includes a new research feature: the Intracardiac Impedance (ICI) measurement. 

 

Solutions for today

• Reduced unnecessary shocks
• Increased CRT effectiveness

Innovations for tomorrow

• Advanced AF and HF management
• MRI access for ICD patients

Your partner at all times

• Efficient patient management

 

World’s only single-chamber ICD system with complete atrial diagnostics.
The unique Lumax 740 VR-T DX and the innovative Linox^smart S DX lead allow reliable rhythm
monitoring in both atrium and ventricle with a single lead.
 

3-channel IEGM (RA, RV, FF) SMART Detection® Complete AF and HF diagnostics BIOTRONIK Home Monitoring®

 

For information about Linox^smart  click here

 

 

 

Innovative sensor technologies for CRT optimization, built in.
The innovative intracardiac impedance measurement featured by Lumax 740 HF-T provides
electrical measures that strongly correlate to LV volume changes⁵ (research feature).

 

Potential future applications of intracardiac impedance monitoring:

• Intraoperative optimization of left ventricular lead site⁶
• Automatic optimization of AV and VV delay⁶
• Continuous monitoring of heart failure progression and cardiac remodeling processes⁷

 

Monitoring of patients’ heart failure statuses, seamlessly.
BIOTRONIK Heart Failure Monitor and BIOTRONIK Home Monitoring^® allow continuous monitoring and remote evaluation of patients’ heart failure (HF) conditions.